Peter John Brodhead’s Guides

Peter John Brodhead

Cleveland Defective and Dangerous Products Attorney.

Contributor Level 4
  1. Pradaxa Internal Bleeding Lawsuit Timeline and Resources

    Written by attorney Peter Brodhead, almost 2 years ago.

    October 19, 2010: The FDA approved Pradaxa (pdf) to prevent blood clot and stroke in people with atrial fibrillation. March 30, 2011: The FDA released a safety alert (pdf) stating that Pradaxa should only be prescribed and stored in its original container or blister package. Nove...

    3 people found this Legal Guide helpful

  2. Fresenius GranuFlo and NaturaLyte Lawsuit Timeline and Resources

    Written by attorney Peter Brodhead, almost 2 years ago.

    February 19, 2003: Fresenius Medical Care submitted its application to the FDA for 510(k) clearance (pdf) of Naturalyte Granuflo Dry Acid Concentrate 10XX Series, 24XX Series, 30XXseries. "A 510(k) is a premarket submission made to FDA to demonstrate that the device to be markete...

    3 people found this Legal Guide helpful

  3. Medtronic Infuse Bone Graft Lawsuit Timeline and Resources

    Written by attorney Peter Brodhead, almost 2 years ago.

    July 2, 2002: The FDA sent Medtronic an approval letter (pdf) in response to its premarket approval application for the InFUSE Bone Graft medical device. Per that letter and the Medical Devices Approvals and Clearances section of the FDA's website (pdf), Medtronic's Infuse Bone G...

    3 people found this Legal Guide helpful

  4. Timeline of Events Leading to Zofran Recall

    Written by attorney Peter Brodhead, almost 2 years ago.

    January 4, 1991: The FDA approved Zofran (ondansetron) for chemotherapy-related nausea and vomiting (pdf). January 5, 1993: The New York Times reported that the FDA approved a pill form of Zofran (pdf). June 22, 1995: GlaxoWellcome submited a New Drug Application to the FDA for a...

    3 people found this Legal Guide helpful

  5. NECC Fungal Meningitis Outbreak Timeline of Events

    Written by attorney Peter Brodhead, almost 2 years ago.

    April 15, 2011: Colorado issued a cease-and-desist order (pdf) to NECC for shipping drugs to the state without requiring individual prescriptions for each drug. September 21, 2012: The Tennessee Department of Health notified the CDC that a patient developed meningitis about 19 d...

    3 people found this Legal Guide helpful

  6. Drug Injury Lawyer Peter Brodhead Discusses the Drug Causing the NECC Fungal Meningitis Outbreak

    Video posted by attorney Peter Brodhead, almost 2 years ago.

    What is the drug involved in the NECC Fungal Meningitis Outbreak? It is called methylprednisone, and it is from one company, New England Compounding center, or NECC. It was shipped to 23 states, and there are over 17,000 vials of this product that have been recalled due to their ...

    1 person found this Legal Guide helpful

  7. Defective Drug Injury Lawyer Peter Brodhead Discusses NECC Fungal Meningitis Outbreak Lawsuit

    Video posted by attorney Peter Brodhead, almost 2 years ago.

    The NECC fungal meningitis outbreak is not your typical pharmaceutical case. Most drug injury cases involve some defect in the drug or in the warning or in the design of the drug. This case is different because the central issue is proving what the cause of the contamination of t...

    2 people found this Legal Guide helpful

  8. Medtronic Infuse Lawyer Peter Brodhead Discusses the Medtronic Infuse Bone Graft Lawsuit

    Video posted by attorney Peter Brodhead, almost 2 years ago.

    In 2002, the FDA gave limited permission to a company called Medtronic to market its new medical device called the Infuse Bone Implant System. This permission was limited to a frontal surgical approach to a small section of the lower spine. It is against the law for a company to ...

    1 person found this Legal Guide helpful